ARK Investment Management Portfolio holdings
ARK Investment Management LLC, founded in 2014 by Cathie Wood and headquartered in St. Petersburg, Florida, is an investment firm managing over $15 billion in assets as of late 2024, renowned for its focus on disruptive innovation across thematic equity ETFs. With a mission to invest in technologies shaping the future, ARK targets five key areas—artificial intelligence, genomics, autonomous technology, energy storage, and blockchain—offering funds like the ARK Innovation ETF (ARKK) to retail and institutional investors seeking high-growth opportunities. Wood, a former AllianceBernstein economist, leads a team of about 50, emphasizing active management, deep research, and a long-term horizon, often holding volatile, speculative stocks like Tesla and Coinbase, which fueled massive gains in 2020 but faced challenges in 2022’s bear market. Known for its transparent, educational approach—including daily portfolio disclosures and bold predictions like Bitcoin reaching $1 million—ARK has carved a niche as a forward-thinking, risk-embracing player in the investment landscape.
Top Buys
| 1 |
Tesla
TSLA
|
$91.5M |
| 2 |
XLNX
Xilinx Inc
XLNX
|
$43.5M |
| 3 |
TWOU
2U, Inc.
TWOU
|
$33.4M |
| 4 |
CRISPR Therapeutics
CRSP
|
$33M |
| 5 |
Nutanix
NTNX
|
$31.8M |
Top Sells
| 1 |
MDSO
Medidata Solutions, Inc.
MDSO
|
$101M |
| 2 |
TWTR
Twitter, Inc.
TWTR
|
$50M |
| 3 |
LendingTree
TREE
|
$49.3M |
| 4 |
Baidu
BIDU
|
$39.2M |
| 5 |
NVIDIA
NVDA
|
$35.7M |
Sector Composition
| 1 | Healthcare | 30.31% |
| 2 | Technology | 26.14% |
| 3 | Communication Services | 11.17% |
| 4 | Financials | 10.19% |
| 5 | Consumer Discretionary | 8.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
151
Evogene
EVGN
$10.5M
| $327K | 0.01% |
20,299
-8,376
| -29% | -$135K |
|
152
MediWound
MDWD
$182M
| $325K | 0.01% |
+13,728
| New | +$325K |
|
|
CEL
153
DELISTED
Cellcom Israel, Ltd.
CEL
| $319K | 0.01% |
110,305
+25,328
| +30% | +$73.2K |
|
154
Teva Pharmaceuticals
TEVA
$21.2B
| $318K | 0.01% |
34,407
+9,945
| +41% | +$91.9K |
|
155
Thermo Fisher Scientific
TMO
$185B
| $263K | 0.01% |
+897
| New | +$263K |
|
156
MSCI
MSCI
$43.1B
| $143K | ﹤0.01% |
597
-186
| -24% | -$44.6K |
|
157
Fiserv
FI
$74B
| $98K | ﹤0.01% |
1,078
-795
| -42% | -$72.3K |
|
|
AKE
158
DELISTED
SAFETY FIRST TR PRIN PRO CTFS LKD TO GLBL IND BASKET
AKE
| $90K | ﹤0.01% |
+960
| New | +$90K |
|
|
OPRA
159
Opera Ltd
OPRA
$1.59B
| $77K | ﹤0.01% |
7,342
-3,150
| -30% | -$33K |
|
160
Hexcel
HXL
$5.1B
| $61K | ﹤0.01% |
757
-5
| -0.7% | -$403 |
|
161
Avient
AVNT
$3.41B
| $54K | ﹤0.01% |
1,720
+212
| +14% | +$6.66K |
|
162
Xerox
XRX
$488M
| $53K | ﹤0.01% |
1,489
-532
| -26% | -$18.9K |
|
163
ATI
ATI
$10.6B
| $50K | ﹤0.01% |
1,983
+85
| +4% | +$2.14K |
|
164
Kodak
KODK
$468M
| $50K | ﹤0.01% |
20,712
+5,643
| +37% | +$13.6K |
|
165
Carpenter Technology
CRS
$12B
| $49K | ﹤0.01% |
1,018
-90
| -8% | -$4.33K |
|
166
Eastman Chemical
EMN
$7.88B
| $48K | ﹤0.01% |
616
+26
| +4% | +$2.03K |
|
167
Visa
V
$681B
| $39K | ﹤0.01% |
223
| – | – |
|
|
SGL
168
DELISTED
STRATEGIC GLOBAL INCOME FUND
SGL
| $38K | ﹤0.01% |
+5,553
| New | +$38K |
|
169
DuPont de Nemours
DD
$32.3B
| $32K | ﹤0.01% |
421
+15
| +4% | +$1.14K |
|
|
BAYN
170
DELISTED
BAY NATIONAL CORPORATION
BAYN
| $27K | ﹤0.01% |
+390
| New | +$27K |
|
171
Workday
WDAY
$61.7B
| $19K | ﹤0.01% |
92
-106
| -54% | -$21.9K |
|
172
Sandstorm Gold
SAND
$3.29B
| $16K | ﹤0.01% |
+2,813
| New | +$16K |
|
173
Corteva
CTVA
$49.3B
| $12K | ﹤0.01% |
+421
| New | +$12K |
|
|
EVK
174
DELISTED
Ever-Glory International Group, Inc.
EVK
| $5K | ﹤0.01% |
+1,621
| New | +$5K |
|
|
DSM
175
BNY Mellon Strategic Municipal Bond Fund
DSM
$280M
| $4K | ﹤0.01% |
+445
| New | +$4K |
|